@article{JTD16512,
author = {Renato De Vecchis},
title = {Natriuretic peptide-guided versus clinically guided therapy for chronic heart failure: careful expert clinical management can remove need for biomarker-tailored dosing adjustment},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {11},
year = {2017},
keywords = {},
abstract = {This editorial refers to a randomized controlled trial (RCT), namely the Guided Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) study conducted by Felker and colleagues, whose results have been recently published (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/16512}
}